What is testosterone undecanoate?
Testosterone undecanoate is a long-acting esterified form of testosterone that requires injection only every 10 to 14 weeks, or can be taken orally, making it useful for patients seeking less frequent dosing intervals in testosterone replacement therapy.
Testosterone undecanoate differs from shorter-acting esters because it contains an 11-carbon undecanoic acid chain, which slows its release into the bloodstream. This extended half-life means patients require far fewer injections than with other testosterone formulations. Most clinics administer undecanoate injections intramuscularly every 10 to 14 weeks, compared to weekly or biweekly schedules for other esters.
The injectable version is marketed under brand names including Aveed and Nebido in the United States and elsewhere. This form comes as an oily solution and requires careful injection technique, typically given in the glute or lateral thigh. The oral formulation (Andriol) provides an alternative for patients who prefer avoiding needles, though it requires more frequent dosing, typically multiple times daily with food to ensure absorption.
For men in testosterone replacement therapy, the infrequent injection schedule appeals to those managing busy lifestyles or seeking to reduce injection burden. However, the long interval between doses means any side effects or adverse reactions persist longer before the hormone clears the system. TRT providers in Florida assess whether undecanoate suits individual health profiles, monitoring hormone levels and symptoms across the full dosing cycle to maintain stable therapeutic ranges.